ArticleNPJ breast cancer2024

GATA3 and markers of epithelial-mesenchymal transition predict long-term benefit from tamoxifen in ER-positive breast cancer.

Josefine Sandström et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.